We are live on ! Find out more
MIM

MetLife Investment Management Portfolio holdings

AUM $19.6B
1-Year Est. Return 32.64%
This Fund
S&P 500
This Quarter Est. Return
+4.9%
1 Year Est. Return
+32.64%
3 Year Est. Return
+107.14%
5 Year Est. Return
+140.16%
10 Year Est. Return
–
AUM
$16.8B
AUM Growth
+$1.95B
Cap. Flow
+$1.49B
Cap. Flow %
8.85%
Top 10 Hldgs %
30.31%
Holding
2,964
New
179
Increased
2,266
Reduced
433
Closed
84

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$118M
2
AAPL icon
Apple
AAPL
+$96.6M
3
NVDA icon
NVIDIA
NVDA
+$91.2M
4
AMZN icon
Amazon
AMZN
+$67.2M
5
META icon
Meta Platforms (Facebook)
META
+$38.6M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$92.7M
2
SMCI icon
Super Micro Computer
SMCI
+$18M
3
PXD
Pioneer Natural Resource Co.
PXD
+$14.4M
4
IWF icon
iShares Russell 1000 Growth ETF
IWF
+$14.1M
5
MSTR icon
Strategy Inc
MSTR
+$10.4M

Sector Composition

Rank Sector Weight
1 Technology 30.48%
2 Financials 11.78%
3 Healthcare 11.37%
4 Consumer Discretionary 10.49%
5 Industrials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WTM icon
2676
White Mountains Insurance
WTM
$5.04B
$81.8K ﹤0.01%
45
-4
-8% -$7.08K
STRS
2677
DELISTED
STRATUS PPTYS INC
STRS
$81.8K ﹤0.01%
+3,242
New +$76.3K
PAYS icon
2678
Paysign
PAYS
$739M
$81.6K ﹤0.01%
+18,927
New +$83.5K
ESCA icon
2679
Escalade
ESCA
$288M
$81.4K ﹤0.01%
5,900
+554
+10% +$7.42K
PROK icon
2680
ProKidney
PROK
$306M
$80.9K ﹤0.01%
+32,871
New +$88.2K
GBIO
2681
DELISTED
Generation Bio
GBIO
$80.1K ﹤0.01%
2,840
+404
+17% +$13.1K
CRBU icon
2682
Caribou Biosciences
CRBU
$167M
$80K ﹤0.01%
48,759
+8,069
+20% +$25.8K
REAL icon
2683
The RealReal
REAL
$1.35B
$79.7K ﹤0.01%
+24,989
New +$92.2K
QIPT
2684
DELISTED
Quipt Home Medical
QIPT
$79.5K ﹤0.01%
24,700
+2,319
+10% +$8.32K
MYFW icon
2685
First Western Financial
MYFW
$307M
$78.5K ﹤0.01%
+4,620
New +$75.7K
RMAX icon
2686
RE/MAX Holdings
RMAX
$268M
$78.5K ﹤0.01%
9,695
+5,387
+125% +$43.7K
AAOI icon
2687
Applied Optoelectronics
AAOI
$12.2B
$78K ﹤0.01%
+9,414
New +$103K
LCTX icon
2688
Lineage Cell Therapeutics
LCTX
$273M
$78K ﹤0.01%
78,181
+8,472
+12% +$9.36K
TDUP icon
2689
ThredUp
TDUP
$411M
$77.6K ﹤0.01%
45,658
+6,025
+15% +$11K
VTYX
2690
DELISTED
Ventyx Biosciences
VTYX
$77.1K ﹤0.01%
33,395
+8,339
+33% +$34.6K
BMEA icon
2691
Biomea Fusion
BMEA
$93.5M
$76.7K ﹤0.01%
17,037
+6,391
+60% +$65K
RNAC icon
2692
Cartesian Therapeutics
RNAC
$265M
$76.7K ﹤0.01%
+2,838
New +$67.7K
JAKK icon
2693
Jakks Pacific
JAKK
$288M
$76.5K ﹤0.01%
4,272
+401
+10% +$7.91K
SWIM icon
2694
Latham Group
SWIM
$902M
$75.7K ﹤0.01%
+24,976
New +$87K
MSGS icon
2695
Madison Square Garden
MSGS
$10.4B
$75.4K ﹤0.01%
401
+39
+11% +$7.23K
ORN icon
2696
Orion Group Holdings
ORN
$399M
$74.6K ﹤0.01%
+7,843
New +$69.3K
TALK icon
2697
Talkspace
TALK
$869M
$74.5K ﹤0.01%
+32,376
New +$93.1K
FCEL icon
2698
FuelCell Energy
FCEL
$1.7B
$74.1K ﹤0.01%
3,867
+1,776
+85% +$47.6K
LZM icon
2699
Lifezone Metals
LZM
$352M
$74.1K ﹤0.01%
+9,646
New +$75.2K
CRD.A icon
2700
Crawford & Co Class A
CRD.A
$635M
$73.9K ﹤0.01%
+8,555
New +$79.3K
106 107
108
109 110

Similar funds

SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BG
Bahl & Gaynor Cincinnati, Ohio $19.8B AUM 19.53% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

MetLife Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, MetLife Investment Management held 2,964 positions worth $16.8B, up 13% from $14.9B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

MetLife Investment Management deployed $1.49B of net new capital in Q2 2024, opening 179 new positions and adding to 2,266 existing holdings. Its largest new stake was GE Vernova: 73,079 shares worth $12.5M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $92.7M trimmed.

  • MetLife Investment Management's largest Q2 2024 buy was GE Vernova: 73,079 shares worth $12.5M.
  • MetLife Investment Management added most to Microsoft in Q2 2024, an estimated $118M increase.
  • MetLife Investment Management's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $92.7M.
  • MetLife Investment Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $14.4M.
  • MetLife Investment Management's ten largest holdings make up 30% of its $16.8B portfolio in Q2 2024.
  • MetLife Investment Management opened 179 new positions and closed 84 in Q2 2024.
  • MetLife Investment Management's portfolio value rose 13% quarter-over-quarter to $16.8B.

Based on MetLife Investment Management's 13F filing for Q2 2024, filed 13 Aug 2024.